Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake
Recruiting
Observational Study
Chronic Kidney Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- Scaled Insights · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Scaled Insights Behavioral AI will be used to improve clinicians ability to detect and understand: The likelihood of patients with kidney failure opting for peritoneal dialysis and to select the right personalized nudge to get CKD patients to choose peritoneal dialysis
Scaled Insights' can utilize the data from this study to develop individualized nudges for healthcare professionals that can be b…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Phase 1: US and UK adult patients aged 18+ years, with Chronic Kidney Disease stage 4-5.
* Phase 2: US and UK adult patients aged 18+ years, with Chronic Kidney Disease stage 4-5.
Exclusion Criteria:
* Phase 1: Young people aged \<18 years. People who do not have Chronic …
Contacts